These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 133792)

  • 21. [Neuroleptic effect of baclofen in chronic schizophrenia (author's transl)].
    Kuhn R
    Arzneimittelforschung; 1976; 26(6):1187. PubMed ID: 989412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of chronic diffuse arachnoiditis with aminalon].
    Garkusha LG; Kukhtevich II; Proskurkina OA
    Vrach Delo; 1978 Jan; (1):114-6. PubMed ID: 625923
    [No Abstract]   [Full Text] [Related]  

  • 23. Antispastic medication. A review.
    Mårtensson A
    Scand J Rehabil Med; 1981; 13(4):143-7. PubMed ID: 6750782
    [No Abstract]   [Full Text] [Related]  

  • 24. Reserpine action in Huntington's chorea.
    Calabrese VP
    N Engl J Med; 1973 Jul; 289(2):104. PubMed ID: 4267988
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacologic and surgical therapy for spasticity.
    Tibbs PA; Young AB; Walsh JW; Bean JR
    J Ky Med Assoc; 1981 Jun; 79(6):359-62. PubMed ID: 7264443
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
    Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
    Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of flexor spasms with Lioresal.
    Shahani BT; Young RR
    Arch Phys Med Rehabil; 1974 Oct; 55(10):465-7. PubMed ID: 4153400
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antispastic treatment of paraplegic patients].
    Azouvi P; Roby-Brami A; Tougeron A; Bussel B
    Rev Prat; 1988 Oct; 38(25):1806-9. PubMed ID: 3194691
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of certain preparations of gamma-aminobutyric acid in diseases of the nervous system].
    Lukashevich LP; Samosiuk IZ; Filonchik AA
    Vrach Delo; 1975 Jul; (7):48-51. PubMed ID: 1220229
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gammalon in the rehabilitation in infantile cerebral palsy].
    Gershman RN; Vasilenko MA; Iliushina GG; Iakimenko GD; Iakovleva SM
    Pediatr Akus Ginekol; 1977 Dec; (6):26-7. PubMed ID: 343053
    [No Abstract]   [Full Text] [Related]  

  • 31. [Huntington's chorea].
    Benarroch EE
    Medicina (B Aires); 1981; 41(1):114-8. PubMed ID: 6455582
    [No Abstract]   [Full Text] [Related]  

  • 32. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Neurol Clin; 1988 Feb; 6(1):159-72. PubMed ID: 2967909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A quantitative evaluation of the effect of diazepam in Huntington's chorea.
    Farrell DF; Hofmann WW
    Arch Phys Med Rehabil; 1968 Oct; 49(10):586-91. PubMed ID: 4234777
    [No Abstract]   [Full Text] [Related]  

  • 35. Baclofen in chronic schizophrenia.
    Bigelow LB
    Psychopharmacol Bull; 1977 Jan; 13(1):4-5. PubMed ID: 319473
    [No Abstract]   [Full Text] [Related]  

  • 36. [GH after baclofen and diazepam].
    Carletti P; Morosini PP; Ferretti GF; Campanella N
    Boll Soc Ital Biol Sper; 1981 Dec; 57(23):2351-4. PubMed ID: 6279128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of the overall treatment of neurosensory hearing disorders using aminalone].
    Tsyganov AI; Ozinkovskiĭ VV
    Zh Ushn Nos Gorl Bolezn; 1977; (6):18-21. PubMed ID: 339592
    [No Abstract]   [Full Text] [Related]  

  • 39. Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid.
    Shoulson I; Kartzinel R; Chase TN
    Neurology; 1976 Jan; 26(1):61-3. PubMed ID: 128707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
    Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
    J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.